217 related articles for article (PubMed ID: 15507522)
21. Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells.
Jiao Y; Zhang W; Liu J; Ni W; Xu W; Jin J; Qian W
Cancer Biol Ther; 2007 Aug; 6(8):1186-92. PubMed ID: 17643074
[TBL] [Abstract][Full Text] [Related]
22. Screening of telomerase inhibitors.
Kleideiter E; Piotrowska K; Klotz U
Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
[TBL] [Abstract][Full Text] [Related]
23. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
[TBL] [Abstract][Full Text] [Related]
24. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
[TBL] [Abstract][Full Text] [Related]
25. Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.
Bryan C; Rice C; Hoffman H; Harkisheimer M; Sweeney M; Skordalakes E
Structure; 2015 Oct; 23(10):1934-1942. PubMed ID: 26365799
[TBL] [Abstract][Full Text] [Related]
26. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
27. Perifosine as a potential novel anti-telomerase therapy.
Holohan B; Hagiopian MM; Lai TP; Huang E; Friedman DR; Wright WE; Shay JW
Oncotarget; 2015 Sep; 6(26):21816-26. PubMed ID: 26307677
[TBL] [Abstract][Full Text] [Related]
28. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
29. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
30. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
31. Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
Kusoglu A; Goker Bagca B; Ozates Ay NP; Gunduz C; Biray Avci C
Gene; 2020 Oct; 759():145001. PubMed ID: 32738420
[TBL] [Abstract][Full Text] [Related]
32. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
Pandya VA; Crerar H; Mitchell JS; Patani R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Pascolo E; Wenz C; Lingner J; Hauel N; Priepke H; Kauffmann I; Garin-Chesa P; Rettig WJ; Damm K; Schnapp A
J Biol Chem; 2002 May; 277(18):15566-72. PubMed ID: 11854300
[TBL] [Abstract][Full Text] [Related]
34. Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.
Röth A; Dürig J; Himmelreich H; Bug S; Siebert R; Dührsen U; Lansdorp PM; Baerlocher GM
Leukemia; 2007 Dec; 21(12):2456-62. PubMed ID: 17898784
[TBL] [Abstract][Full Text] [Related]
35. A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.
Benslimane Y; Sánchez-Osuna M; Coulombe-Huntington J; Bertomeu T; Henry D; Huard C; Bonneil É; Thibault P; Tyers M; Harrington L
Aging Cell; 2021 Apr; 20(4):e13331. PubMed ID: 33660365
[TBL] [Abstract][Full Text] [Related]
36. Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.
Yu W; Qin X; Jin Y; Li Y; Santiskulvong C; Vu V; Zeng G; Zhang Z; Chow M; Rao J
Oncotarget; 2017 Jan; 8(5):7977-7988. PubMed ID: 28002788
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532.
Liu C; Zhou H; Sheng XB; Liu XH; Chen FH
Bioorg Chem; 2020 Sep; 102():104077. PubMed ID: 32682156
[TBL] [Abstract][Full Text] [Related]
38. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells.
Wang JC; Warner JK; Erdmann N; Lansdorp PM; Harrington L; Dick JE
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14398-403. PubMed ID: 16172394
[TBL] [Abstract][Full Text] [Related]
40. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
